Table 1 In-silico and in-vivo CBF.

From: Lumped-parameter model as a non-invasive tool to assess coronary blood flow in AAOCA patients

ID

AN

CBF at rest (ml/s)

CBF at Hyperemia (ml/s)

LCA

RCA

LCA

RCA

In-silico

In-vivo

Rel diff

In-silico

In-vivo

Rel diff

In-silico

In-vivo

Rel diff

In-silico

In-vivo

Rel diff

1

RCA

1.65

1.72

−0.04

0.76

0.75

0.01

7.54

7.75

−0.03

6.84

6.25

0.09

2

LCA

1.03

1.02

0.01

1.72

1.73

−0.01

5.24

5.05

−0.41

5.30

5.53

−0.04

3

RCA

0.91

0.97

−0.06

2.66

2.67

0.00

3.50

3.47

0.01

4.66

4.77

−0.02

4

RCA

1.68

1.75

−0.04

1.06

1.03

0.02

7.41

7.23

0.02

4.37

3.53

0.24

5

RCA

2.06

2.23

−0.08

1.04

1.23

−0.16

6.02

6.20

−0.03

3.21

4.03

−0.20

6

RCA

1.60

1.73

−0.07

1.23

1.25

−0.01

8.21

7.25

0.13

4.67

4.58

0.02

7

LCA

1.04

1.13

−0.08

1.79

1.85

−0.03

5.90

5.65

0.04

5.29

4.13

0.28

8

LCA

1.05

1.07

−0.01

1.37

1.33

0.03

9.89

8.70

0.14

5.73

5.25

0.09

9

RCA

2.82

3.22

−0.12

0.871

0.87

0.00

7.25

6.73

0.08

3.93

2.83

0.39

10

RCA

1.25

1.37

−0.09

0.79

0.83

−0.05

2.98

3.00

−0.01

2.76

2.45

0.13

11

RCA

1.21

1.18

0.02

0.43

0.43

0.00

5.83

5.62

0.04

2.45

2.33

0.05

12

RCA

9.76

10.32

−0.05

0.96

1.02

−0.06

13.84

14.22

−0.03

3.30

2.98

0.11

13

RCA

1.78

1.48

0.20

1.04

1.13

−0.08

4.16

2.85

0.46

2.25

2.32

−0.08

14

RCA

1.13

1.18

−0.04

0.87

0.90

−0.03

5.61

5.72

−0.02

3.48

3.53

−0.02

15

RCA

2.45

2.50

−0.02

2.13

2.03

0.05

3.62

3.62

0.00

3.02

2.83

0.07

16

LCA

3.59

3.43

0.05

4.11

3.98

0.03

7.55

7.13

0.06

8.33

7.45

0.12

17

RCA

1.77

1.73

0.02

1.96

2.08

−0.06

5.51

5.02

0.10

4.43

3.03

0.46

18

LCA

1.33

1.78

−0.25

3.67

3.65

0.01

6.79

6.32

0.07

7.31

7.07

0.03

19

RCA

0.71

0.83

−0.15

0.74

0.97

−0.23

2.08

2.57

−0.19

1.97

2.50

−0.21

25% percentile

1.05

1.13

−0.08

0.87

0.90

−0.06

4.16

3.62

−0.02

3.02

2.83

−0.02

Median

1.60

1.72

−0.04

1.06

1.23

−0.01

5.90

5.72

0.04

4.37

3.53

0.07

75% Percentile

2.06

2.23

−0.01

1.96

2.03

0.01

7.54

7.23

0.08

5.30

5.25

0.13

  1. In-silico computed CBF, in-vivo measured CBF , and respective relative differences (rel diff) are reported for all patients considered in both hemodynamic conditions analyzed (rest and hyperemia). For each patient the anomalous CA is highlighted: left CA (LCA) /right CA (RCA). Median, 25\(\%\) percentile, and 75\(\%\) percentile of CBF value are also reported